Skip to main navigation Skip to search Skip to main content

Serum dopamine-β-hydroxylase in familial dysautonomia

  • Lewis S. Freedman*
  • , Richard P. Ebstein
  • , Menek Goldstein
  • , Felicia B. Axelrod
  • , Joseph Dancis
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The mean value of serum dopamine-β-hydroxylase (DβH) in patients with familial dysautonomia, 1 to 5 years of age, does not differ significantly from control children of the same age (24.0 ± 21.06 S.D. as compared to 34.0 ± 33.12). Among patients 6 years of age and over, the mean value was slightly but significantly lower than in control subjects (62.7 ± 49.61, as compared to control values of 86.1 ± 54.31 p < 0.025). However, the determination of serum DβH does not contribute to the diagnosis of familial dysautonomia because well over half the children have levels within 1 S.D. of the mean levels of the control subjects. There is no correlation with clinical symptomatology. The disease process may tend to depress the level of serum DβH but the effect is neither consistent nor decisive.

Original languageEnglish
Pages (from-to)1008-1012
Number of pages5
JournalJournal of Laboratory and Clinical Medicine
Volume85
Issue number6
StatePublished - Jun 1975
Externally publishedYes

Fingerprint

Dive into the research topics of 'Serum dopamine-β-hydroxylase in familial dysautonomia'. Together they form a unique fingerprint.

Cite this